Cited by 406Liver physiology and pathologyCholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and Prognosis

Necroptosis microenvironment directs lineage commitment in liver cancer

Open access
Seehawer, Marco, Heinzmann, Florian, D’Artista, Luana, Harbig, Jule, Roux, Pierre-François, Hoenicke, Lisa, Dang, Hien, Klotz, Sabrina +16 more·2018·Nature

Abstract

Primary liver cancer represents a major health problem. It comprises hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), which differ markedly with regards to their morphology, metastatic potential and responses to therapy. However, the regulatory molecules and tissue context that commit transformed hepatic cells towards HCC or ICC are largely unknown. Here we show that the hepatic microenvironment epigenetically shapes lineage commitment in mosaic mouse models of liver tumorigenesis. Whereas a necroptosis-associated hepatic cytokine microenvironment determines ICC outgrowth from oncogenically transformed hepatocytes, hepatocytes containing identical oncogenic drivers give rise to HCC if they are surrounded by apoptotic hepatocytes. Epigenome and transcriptome profiling of mouse HCC and ICC singled out Tbx3 and Prdm5 as major microenvironment-dependent and epigenetically regulated lineage-commitment factors, a function that is conserved in humans. Together, our results provide insight into lineage commitment in liver tumorigenesis, and explain molecularly why common liver-damaging risk factors can lead to either HCC or ICC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-018-0519-y

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Seehawer, M., Heinzmann, F., D’Artista, L., Harbig, J., Roux, P.-F., Hoenicke, L., Dang, H., Klotz, S., Robinson, L., Doré, G., Rozenblum, N., Kang, T.-W., Chawla, R., Buch, T., Vucur, M., Roth, M., Zuber, J., Luedde, T., Sipos, B., Longerich, T., Heikenwälder, M., Wang, X. W., Bischof, O., & Zender, L.
Affiliations
  • Universitätsklinikum Tübingen (DE)
  • Inserm (FR)
  • National Cancer Institute (US)
  • Institut Pasteur (FR)
  • University of Zurich (CH)
  • Universitätsklinikum Aachen (DE)
  • Research Institute of Molecular Pathology (AT)
  • University of Tübingen (DE)
  • University Hospital Heidelberg (DE)
  • German Cancer Research Center (DE)
Corresponding author
Zender, Lars
Venue
Nature
Published
2018-09-12
Volume
562
Issue
7725
Pages
69-75
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2890271012
Cited by
406
References
47
Citations by year
2026: 11 · 2025: 43 · 2024: 40 · 2023: 82 · 2022: 83 · 2021: 60 · 2020: 39 · 2019: 43 · 2018: 5
FWCI
23.03
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (Z01BC010313, R01CA136533)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
necroptosis, tumor microenvironment, lineage commitment, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, hepatocarcinogenesis, epigenetic regulation, TBX3, PRDM5, apoptosis, hepatocyte transformation, cytokine microenvironment
MeSH terms
Animals, Cell Differentiation, Disease Models, Animal, DNA Transposable Elements, DNA-Binding Proteins, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Mosaicism, Necrosis, Genes, ras, Transcription Factors, Cytokines, Genes, myc, Apoptosis, Cholangiocarcinoma, Cell Lineage, Cyclin-Dependent Kinase Inhibitor p16, T-Box Domain Proteins, Gene Expression Profiling, Hepatocytes, Epigenesis, Genetic, Proto-Oncogene Proteins c-akt, Mice, Tumor Microenvironment, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review